| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 2.170 | 29.627 | 25.766 | 24.161 | 30.694 | 45.158 | 12.850 |
| Total Income - EUR | - | - | - | 2.170 | 29.627 | 25.766 | 24.161 | 30.694 | 45.158 | 12.850 |
| Total Expenses - EUR | - | - | - | 254 | 396 | 443 | 480 | 657 | 14.112 | 6.263 |
| Gross Profit/Loss - EUR | - | - | - | 1.916 | 29.231 | 25.324 | 23.682 | 30.037 | 31.046 | 6.588 |
| Net Profit/Loss - EUR | - | - | - | 1.850 | 28.342 | 24.609 | 22.972 | 29.330 | 30.604 | 6.017 |
| Employees | - | - | - | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Pobirci Medical S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | - | - | 2.213 | 30.826 | 54.592 | 74.428 | 34.670 | 31.883 | 12.820 |
| Inventories | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | 2.170 | 28.098 | 48.695 | 64.909 | 30.961 | 26.652 | 12.731 |
| Cash | - | - | - | 43 | 2.728 | 5.897 | 9.519 | 3.709 | 5.231 | 89 |
| Shareholders Funds | - | - | - | 1.893 | 30.199 | 54.236 | 74.270 | 29.419 | 30.693 | 6.106 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 81 | 81 | 80 |
| Debts | - | - | - | 319 | 627 | 356 | 158 | 5.251 | 1.191 | 6.714 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Pobirci Medical S.r.l.